GI
GBIO

GAMMA Investing’s Generation Bio GBIO Stock Holding History

GAMMA Investing’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5
Closed -$124 – 3797
2024
Q3 		$124 Sell
5
-3
-38% -$79 ﹤0.01% 3553
2024
Q2 		$223 Hold
8
– – ﹤0.01% 3312
2024
Q1 		$322 Hold
8
– – ﹤0.01% 3168
2023
Q4 		$149 Buy
+8
New +$139 ﹤0.01% 3133

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

GAMMA Investing's GBIO Position: Q4 2024 in Review

GAMMA Investing sold out of Generation Bio (GBIO) in Q4 2024, closing a stake of 5 shares — an estimated $124 sold.

GAMMA Investing first reported a position in GBIO in Q4 2023 and held it in 4 quarters. The position peaked at $322 in Q1 2024. 78 funds tracked by Wall St. Rank hold GBIO as of Q4 2024.

  • GAMMA Investing reported no remaining Generation Bio position as of Q4 2024 after selling out during the quarter.
  • GAMMA Investing sold 5 Generation Bio shares in Q4 2024, an estimated $124.
  • GAMMA Investing first reported a position in Generation Bio in Q4 2023 and held it in 4 quarters.
  • GAMMA Investing's Generation Bio position peaked at $322 in Q1 2024.
  • 78 funds tracked by Wall St. Rank held Generation Bio as of Q4 2024.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.